经皮穿刺置管引流并硬化治疗肾囊肿

目的探讨影像引导下经皮肾囊肿穿刺置管外引流并酒精硬化术的治疗方法和临床应用价值。方法对24例原发性肾囊肿患者进行了影像引导下的经皮穿刺置管引流及无水酒精硬化治疗。结果24例患者共26个囊腔,共穿刺26次,均成功,成功率100％。放置5F多侧孔导管或7F引流管26根。经引流管共注射无水酒精139次,平均5．3次,平均每次17mL。随访1～4年,25个囊肿治愈,治愈率为96．2％。无严重并发症发生。结论影像引导下经皮穿刺肾囊肿置管引流并硬化术,成功率和治愈率高,并发症少。     

B超引导下肾囊肿穿刺无水酒精硬化治疗

目的探讨Ｂ超引导下经皮穿刺注无水酒精治疗肾囊肿的临床价值及囊肿穿刺的指征。方法５８例肾囊肿患者接受Ｂ超引导下肾囊肿穿刺无水酒精硬化治疗术。结果单纯性囊肿有效率为９８．４％,治愈率为８３．９％。穿刺后无严重并发症,多囊肾的治疗也取得了较满意的效果。结论无水酒精肾囊肿硬化疗效确切,值得推广应用。     

B超引导下经皮穿刺肾囊肿硬化治疗的疗效观察与护理

目的超声引导下无水酒精注射治疗单纯性肾囊肿的观察和护理。方法68例肾囊肿患者，在超声引导下经皮穿刺肾囊肿抽液后向肾囊肿内注射无水酒精。结果本组68例患者中，囊腔内注射无水酒精治疗2次1例，其余均1次成功。治疗前囊腔直径最大22cm，最小3．9cm，平均8．2cm，治疗后囊腔均明显缩小，68例患者症状恢复均较好．腹胀、腹痛减轻或缓解，无一例患者出现并发症。结论超声导向下经皮穿刺肝肾卵巢囊肿抽液加无水酒精灌洗法是一种高疗效、短疗程、并发症少的方法。     

B超引导穿刺硬化治疗单纯性肾囊肿42例报告

目的:观察超声引导下细针穿刺抽吸及注射无水酒精硬化治疗肾囊肿的临床疗效。方法:在B超引导下对42例患者45个肾囊肿抽液后注入无水酒精治疗,术后定期复查。结果:本组42例(45个囊肿)治疗后定期随访,术后6个月复查B超,囊肿消失18个(40.0%),14个(31.1%)囊肿直径小于穿刺前直径的1/3,9个(20.0%)囊肿直径为穿刺前直径的1/3～2/3,4个(8.9%)囊肿直径大于穿刺前直径2/3,无1例囊肿较穿刺前增大。结论:B超引导下细针穿刺抽吸及注射无水酒精硬化治疗肾囊肿定位准确,术中创伤小,术后并发症少,疗效可靠。     

B超引导下穿刺注射无水酒精治疗肝囊肿

本文总结了经B超引导下穿刺注射无水酒精治疗肝囊肿36例,其中男性21例,女性15例。年龄25—74岁。单发性囊肿28例,多发性囊肿8例。采用细针穿刺抽液注无水酒精治疗者26例,采用置管引流后注无水酒精治疗者10例。于1—6月内复查B超,多数囊腔闭合,仅少数残存极少的囊腔。在不具备穿刺     

超声引导经皮硬化和引流治疗胰腺假性囊肿

超声引导经皮硬化和引流治疗胰腺假性囊肿吕国荣，李新丰，王静意，黄好基报道８例超声引导经皮抽液、四环素或／和无水酒精硬化及置管引流治疗胰腺假性囊肿的成功经验，旨在探讨其临床应用价值．本组８例为外伤性或胰腺炎后并发胰腺假性囊肿，近期超声随访含液性病变进行...     

CT引导下肝肾囊肿穿刺置管引流及硬化治疗

目的:分析CT引导下肝肾囊肿穿刺置管引流及硬化治疗的价值。方法:26例病人中肝囊肿14例(男8例,女6例,年龄34～69岁),肾囊肿6例(男5例,女1例,年龄42～58岁),肝囊肿伴肾囊肿6例(男5例,女1例,年龄51～62岁)。所有病人均在CT引导下进行穿刺置管引流及无水酒精硬化治疗。结果:本组病例技术成功率100%、治疗有效率100%,并发症仅为局部疼痛、颜面潮红等,无严重并发症发生。结论:CT引导下肝肾囊肿穿刺置管引流及硬化治疗是一种安全有效的治疗方法。     

巨大肝肾囊肿超声引导置管引流后硬化治疗

目的:分析探讨超声引导置管引流硬化治疗在巨大肝肾囊肿治疗中的效果。方法:将我院2017年1月至2019年11月接诊的22例巨大肝肾囊肿患者作为研究对象,采用超声引导置管引流后硬化治疗,进而观察分析治疗后的临床效果。结果:22例患者入院后,经过临床检查发现单发肝、肾囊肿例数16例,多发性肝肾囊肿6例,巨大囊肿总数为22个;22个囊肿共经过22次穿刺置管引流后,注入聚桂醇硬化治疗,病情复发1例,通过再次穿刺均治愈,穿刺置管过程中没有严重的并发症,临床治疗总有效率达100%。结论:对巨大肝肾囊肿患者施以超声引导穿刺置管引流后硬化治疗可以有效的提升临床治疗效果,并且此种治疗方式具有操作简单、安全性高等优势,值得在临床中大力推广应用。     

经皮穿刺肝肾囊肿硬化剂治疗（附20例报告）

目的：总结通过CT、US定位，在X线透视下经皮穿刺无水酒精硬化治疗肝、肾囊肿的经验。材料与方法：20例肝、肾囊肿经皮穿刺抽吸，无水酒精硬化治疗。其中肝囊肿7例，肾囊肿13例，均为单纯性囊肿。囊肿最大直径为3．8cm～18cm。用21G穿刺针穿刺，抽出囊内液体为50～1400ml，注入无水酒精的量以抽出囊液的1／5～1／4为宜，最多不超过200ml，以免酒清中毒。结果：本组随访时间为1～24个月，疗效为100％，囊肿最大直径缩小至原来的3／10～完全消失，囊肿完全消失率为40％（8／20）。并发症为发热（10％），造影剂外漏（5％），颜面潮红、心悸（10％），无严重并发症发生。结论：经皮穿刺无水酒精硬化术治疗肝、肾囊肿是一种并发症低、简便易行、安全有效的治疗方法。     

超声引导下无水酒精硬化治疗肾囊肿临床研究

目的探讨超声引导下采用无水酒精硬化治疗肾囊肿的疗效。方法45例肾囊肿采用超声引导下无水酒精硬化治疗。结果硬化治疗5个月后复查囊腔明显缩小,1年后囊腔90％消失。结论超声引导下无水酒精硬化治疗肾囊肿可以减轻患者痛苦和经济负担,方法简单易行,是治疗肾囊肿的首选方法。     

Acupuncture treatment of dysmenorrhea resistant to conventional medical treatment

We evaluated the effect of acupuncture on NSAID resistant dysmenorrhea related pain [measured according to Visual Analogue Scale (VAS)] in 15 consecutive patients. Pain was measured at baseline (T1), mid treatment (T2), end of treatment (T3) and 3 (T4) and 6 months (T5) after the end of treatment. Substantial reduction of pain and NSAID assumption was observed in 13 of 15 patients (87%). Pain intensity was significantly reduced with respect to baseline (average VAS=8.5), by 64, 72, 60 or 53% at T2, T3, T4 or T5. Greater reduction of pain was observed for primary as compared with secondary dysmenorrhea. Average pain duration at baseline (2.6 days) was significantly reduced by 62, 69, 54 or 54% at T2, T3, T4 or T5. Average NSAID use was significantly reduced by 63, 74, 58 or 58% at T2, T3, T4 or T5, respectively, and ceased totally in 7 patients, still asymptomatic 6 months after treatment. Our findings suggest that acupuncture may be indicated to treat dysmenorrhea related pain, in particular in those subjects in whom NSAID or oral contraceptives are contraindicated or refused.     

精准医疗下的个体化治疗策略-肺泡蛋白沉积症治疗进展

肺泡蛋白沉积症是一种罕见的临床综合征,以肺泡和细支气管腔内过碘酸雪夫染色阳性的富磷脂蛋白物质蓄积为特征,导致肺通气功能障碍。主要分为3型：自身免疫性、先天性、继发性。目前全肺灌洗术仍然是临床主要的治疗方法,IgG型抗粒细胞 单核细胞集落刺激因子（GM CSF）替代治疗、利妥昔单抗、血浆置换、肺移植等是新兴的治疗方法,但大多数研究仅限于病例报道,通常样本数量有限,证据水平不足,具体的治疗应按照不同的病因分型,选择不同的治疗方案,进行个体化治疗。     

Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment

A randomised double-blind comparison of three treatment strategies in 533 patients with mild-to-moderate hypertension over 6-9 months. The low-dose perindopril/indapamide (PER/IND) combination (2 mg and 0.625 mg, respectively) daily resulted in a significantly better blood pressure control and systolic blood pressure decrease. In addition, the low-dose PER/IND combination showed superior efficacy/safety criteria than the sequential strategy of atenolol (50 mg) then losartan (50 mg) then amlodipine (5 mg), and the step-by-step strategy of valsartan (40 mg then 80 mg then 80 mg plus hydrochlorothiazide 12.5 mg).     

髋臼骨折手术后的康复治疗

目的:对髋臼骨折手术后患者采用功能康复治疗,探讨提高疗效的方法。方法:对64例髋臼骨折手术后患者分期采用不同的康复治疗方法,早期被动活动,主动行肌肉舒缩活动,逐步过渡到负重活动。结果:本组优31例,良26例,一般5例,差2例,优良率89.1%,发生骨性关节炎3例,严重异位骨化3例,深静脉血栓形成1例,坐骨神经损伤1例。结论:髋臼骨折术后进行肢体康复治疗是一种有效的方法。     

Behavioral treatment of chronic pain: variables affecting treatment efficacy

Behavioral approaches to pain management have been shown to be efficacious in many instances but many of the variables indicating or contra-indicating such treatment remain unspecified. The data reported here demonstrated that while patients referred by both Disability and Medical Subspecialties showed improvement in pain report, affect, and feelings of control, those patients referred by Disability improved reliably less, remain hospitalized longer and were reliably less compliant. These data can be understood within an operant conditioning conceptualization of illness behavior.     

慢性颈动脉粥样硬化闭塞治疗的研究进展

慢性颈动脉粥样硬化闭塞会导致脑血流低灌注而增加卒中风险。无症状患者首选药物治疗,对于反复出现神经症状的患者可选择手术治疗。颅外-颅内动脉旁路术(extracranial-intracranial artery bypass,EIAB)治疗效果不优于药物治疗。颈动脉内膜剥脱术(carotid endarterectomy,CEA)、颈动脉支架成形术(carotidartery stent,CAS)手术风险高、成功率低,治疗效果尚待验证,故术前应严格筛选患者、把握适应证。本文就目前对于慢性颈动脉闭塞的治疗现状作一综述。